Flagship Pioneering as of Sept. 30, 2018
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 6 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rubius Therapeutics | 60.8 | $919M | 38M | 24.00 | |
| Evelo Biosciences | 14.7 | $222M | 18M | 12.18 | |
| Denali Therapeutics (DNLI) | 12.8 | $194M | 8.9M | 21.74 | |
| Seres Therapeutics | 6.4 | $96M | 13M | 7.59 | |
| Quanterix Ord (QTRX) | 2.9 | $44M | 2.0M | 21.42 | |
| Syros Pharmaceuticals | 2.5 | $38M | 3.2M | 11.91 |
